Latest Commercialization News

Genetic Signatures reduced its quarterly operating cash outflow to A$1.0 million after restructuring, while commercial testing began under its Danish hospital contract. The company is also advancing an all-scrip Microba merger, but faces a contested shareholder meeting later this month.

Aguia Resources has sold 825 tonnes of Pampafos since 15 September while a 30,000-tonne ore stockpile awaits processing. The progress comes as the company faces an unresolved court challenge to its Tres Estradas phosphate project and begins permitting work at Passo Feio.

ANO says Australian revenue from its Veganic sunscreen products fell 71% in the first quarter of FY27 after customer cancellations linked to media coverage and TGA involvement over product labelling. The company is preparing a legal claim against MooGoo, but no proceedings have yet been filed and the potential amount remains undisclosed.

Environmental Clean Technologies has confirmed MXene formation in two preliminary Flash Joule Heating runs, moving its US-focused programme from laboratory theory to physical product. The harder commercial tests remain ahead: repeatability, customer qualification, scale-up and shareholder approval for the Xenica acquisition and second placement tranche.

Zinc of Ireland has secured firm commitments for a $3.2 million placement to fund ARGO critical-mineral recovery work, VOLTA battery-recycling development and drilling at Kildare. The raise gives the company a defined execution schedule, but adds 180 million new shares before several commercial milestones remain unproven.

Titomic has converted a semiconductor manufacturing validation run into full-rate production, with revenue expected to reach approximately EUR 0.9 million in 2027. The company says the program could rise to about EUR 2.0 million in 2028, although customer and contract details remain undisclosed.

Cynata Therapeutics has launched a fully underwritten $913,000 entitlement offer as it reassesses the future of its Cymerus platform after two major trials failed to demonstrate efficacy. The raise provides short-term funding, but the prospectus warns that further capital may be needed and repeats a material uncertainty over going concern.

Orcoda has expanded workforce volumes under its Wagner and Wellcamp agreement, generating approximately $2.35 million in revenue during the September quarter. The facility is now being scaled towards its current capacity of 1,000 workers per day.

The Calmer Co has secured an initial Coles order for its Fiji Kava FZZR Piña Colada 10-pack, with rollout expected across 583 stores from the week commencing 12 October. The launch comes as sales and supermarket distribution of the company’s existing kava range continue to expand.

Servcorp Limited (ASX:SRV) has posted a third consecutive record year, with underlying profit, free cash flow and dividends all rising sharply. The debt-free workspace operator is guiding to another year of strong cash generation while investing in Saudi Arabia, technology and AI-enabled services.

InFocus is extending its Codexa platform from US sweepstakes gaming into licensed real-money online gambling markets, initially targeting Curaçao and crypto-native operators. Commercial availability is expected in early 2027, but the expansion still depends on product testing, regulatory registration and customer uptake.

Finder Energy is targeting a final investment decision for its Kuda Tasi-Jahal oil project by 30 November, with approvals and engineering largely complete. The decisive hurdles now sit in financing and contract awards, including the rig, shipyard and EPCI packages.